NCT06501924
Clinical Study of DA-002 and DA-005 as a Treatment for Hair Loss
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 11 versions: 11 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Withdrawn before enrolling Sponsor's reason: Sponsor change of formulation Show 5 more changesShow less
- Primary completion pushed from Oct 17, 2025 to Oct 17, 2027
- Enrollment target: estimated 516 to confirmed 0
- Start date: Jan 15, 2025 to Jan 15, 2027
- Eligibility criteria expanded, about 13 words
- Study completion pushed from Dec 12, 2025 to Dec 12, 2027
- Minor Study description expanded, about 6 wordsv10
- Notable Start date: Nov 15, 2024 to Jan 15, 2025v9
- Notable Eligibility criteria revised
- Study description revised
- Minor Interventions: DA-001 (Dietary Supplement), DA-002 (Drug), Placebo Oral Tablet (Dietary Supplement), Placebo Topical Solution (Other), Topical minoxidil… to DA-002 (Drug), DA-005 (Dietary Supplement), Placebo Oral Tablet (Dietary Supplement), Placebo Topical Solution (Other), Topical minoxidil…
- Study title revised
Show 5 earlier versionsHide 5 earlier versions
Notable Start date: Sep 16, 2024 to Nov 15, 2024v6 Show 6 more changesShow less
- Primary completion date: Jul 11, 2025 to Oct 17, 2025
- Study completion date: Sep 12, 2025 to Dec 12, 2025
- Interventions: Daniel Alain Botanical Supplement Treatment for Hair Loss (Dietary Supplement), Topical minoxidil 5% (Drug) to DA-001 (Dietary Supplement), DA-002 (Drug), Placebo Oral Tablet (Dietary Supplement), Placebo Topical Solution (Other), Topical minoxidil…
- Study description expanded, about 40 words
- Study arms: 2 to 3
- Study title expanded, about 3 words
- Notable Primary endpoints: 1 to 2v5
- Minor Primary completion date: Jul 15, 2025 to Jul 11, 2025
- Study completion date: Sep 15, 2025 to Sep 12, 2025
- Start date: Sep 15, 2024 to Sep 16, 2024
- Minor Primary completion date: Mar 15, 2025 to Jul 15, 2025
- Study completion date: Jun 15, 2025 to Sep 15, 2025
- Minor Collaborators: 1 to 2v2
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Target Area Hair Counts
Timeframe: Week [0,12]
Arms and interventions
DA-005Experimental
Oral Botanical Supplement HIF-1a inhibitor
Topical Minoxidil 5%Active comparator
Topical Minoxidil 5%
DA-002Experimental
Topical Alpha 1 Agonist
Dietary supplements: DA-005, Placebo Oral Tablet
Drugs: Topical minoxidil 5%, DA-002
Other: Placebo Topical Solution